DNA repair: Counteragent in mutagenesis and carcinogenesis - Accomplice in cancer therapy resistance

Mutation Research - Reviews in Mutation Research

Volumn 462, Issue 2-3, 2000, Pages 101-105

  Rajewsky, Manfred F ^a   Engelbergs, Jörg ^a   Thomale, Jürgen ^a   Schweer, Torsten ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

Author keywords

DNA modification and gene specific repair; H ras gene; N methyl N nitrosourea vs. N ethyl N nitrosourea; Rat mammary carcinogenesis

Indexed keywords

6 O METHYLGUANINE; ANTINEOPLASTIC AGENT; ETHYLNITROSOUREA; METHYLNITROSOUREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST ADENOCARCINOMA; BREAST CARCINOGENESIS; CARCINOGENESIS; DNA DAMAGE; DNA MODIFICATION; DNA REPAIR; DRUG RESISTANCE; FEMALE; KNOCKOUT GENE; MUTAGENESIS; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; RAT; REVIEW;

ADENOCARCINOMA; ALKYLATING AGENTS; ANIMALS; CARCINOGENS; DNA; DNA ADDUCTS; DNA REPAIR; DRUG RESISTANCE, NEOPLASM; ETHYLNITROSOUREA; FEMALE; GENES, RAS; GUANINE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; MUTAGENS; MUTATION; RATS;

EID: 0034069585     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(00)00020-X     Document Type: Article

References (46)

1. R. Montesano, J. Hall, C.P. Wild, Alkylating agents relating to carcinogenesis in man, in: R. D'Amato, T.J. Slaga, W.H. Farland, C. Henry (Eds.), Relevance of Animal Studies to the Evaluation of Human Cancer Risk, Wiley-Liss, New York, 1992, pp. 175-196.
2. Dipple A. DNA adducts of chemical carcinogens. Carcinogenesis. 16:1995;437-441.
3. M. Schwab, H. Rabes, K. Munk, P.H. Hofschneider (Eds.), Genes and Environment in Cancer, Recent Results in Cancer Res. 154 (1998).
4. International Agency for Research on Cancer, IARC Monographs on the Evaluation of Carcinogenic Risk to Humans, Vol. 1-64, International Agency for Research on Cancer, Lyon, 1972-1995.
5. Karran P., Bignami M. DNA damage tolerance, mismatch repair and genome instability. BioEssays. 16:1994;833-839.
6. Fink D., Zheng H., Nebel S., Norris P.S., Aebi S., Lin T.-Z., Nehmé A., Christen R.D., Haas M., MacLeod C.L., Howell S.B. In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res. 57:1997;1841-1845.
7. Chaney S.G., Sancar A. DNA repair: enzymatic mechanisms and relevance to drug response. J. Natl. Cancer Inst. 88:1996;1346-1360.
8. Rajewsky M.F., Engelbergs J., Thomale J., Schweer T. Relevance of DNA repair to carcinogenesis and cancer therapy. Recent Results in Cancer Res. 154:1998;127-146.
9. Lindahl T., Sedgwick B., Sekiguchi M., Nakabeppu Y. Regulation and expression of the adaptive response to alkylating agents. Annu. Rev. Biochem. 57:1988;133-157.
10. Demple B., Harrison L. Repair of oxidative damage to DNA: enzymology and biology. Annu. Rev. Biochem. 63:1994;915-948.
11. E.C. Friedberg, G.C. Walker, W. Siede, DNA Repair and Mutagenesis, ASM Press, Washington, DC, 1995.
12. Wood R.D. DNA repair in eukaryotes. Annu. Rev. Biochem. 65:1996;135-167.
13. Sancar A. DNA excision repair. Annu. Rev. Biochem. 65:1996;43-81.
14. I.D. Hickson (Ed.), Base Excision Repair of DNA Damage, Landes Bioscience, Austin, 1997.
15. Singer B., Hang B. What structural features determine repair enzyme specificity and mechanism in chemically modified DNA? Chem. Res. Toxicol. 10:1997;713-732.
16. Hess M.T., Schwitter U., Petretta M., Giese B., Naegeli H. Bipartite substrate discrimination by human nucleotide excision repair. Proc. Natl. Acad. Sci. U.S.A. 94:1997;6664-6669.
17. Tu Y., Bates S., Pfeifer G.P. Sequence-specific and domain-specific DNA repair in xeroderma pigmentosum and Cockayne syndrome cells. J. Biol. Chem. 272:1997;20747-20755.
18. Wellinger R.E., Thoma F. Nucleosome structure and positioning modulate nucleotide excision repair in the non-transcribed strand of an active gene. EMBO J. 16:1997;5046-5056.
19. 6-ethylguanine in rat-brain DNA: correlation with nervous system-specific carcinogenesis by ethylnitrosourea. Proc. Natl. Acad. Sci. U.S.A. 71:1974;639-643.
20. Harris C.C. Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair. Carcinogenesis. 10:1989;1536-1566.
21. 6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues. Carcinogenesis. 7:1986;745-749.
22. 6-ethylguanine in DNA: relation to chemosensitivity in vitro and treatment outcome. Cancer Res. 54:1994;4524-4531.
23. Buschfort C., Müller M.R., Seeber S., Rajewsky M.F., Thomale J. DNA excision repair profiles of normal and leukemic human lymphocytes: functional analysis at the single-cell level. Cancer Res. 57:1997;651-658.
24. J. Adamkiewicz, W. Drosdziok, W. Eberhardt, U. Langenberg, M.F. Rajewsky, High-affinity monoclonal antibodies specific for DNA components structurally modified by alkylating carcinogens, in: B.A. Bridges, B.E. Butterworth, I.B. Weistein (Eds.), Indicators of Genotoxic Exposure, Banbury Report 13, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1982, pp. 265-276.
25. J. Thomale, J. Engelbergs, F. Seiler, M.F. Rajewsky, Monoclonal antibody-based quantification and repair analysis of specific alkylation products in DNA, in: G.P. Pfeifer (Ed.), Technologies for Detection of DNA Damage and Mutations, Plenum, New York, 1996, pp. 87-101.
26. 6-ethylguanine in DNA protects rat 208F cells from tumorigenic conversion by N-ethyl-N-nitrosourea. Proc. Natl. Acad. Sci. U.S.A. 87:1990;9883-9887.
27. 6-alkylguanine-DNA alkytransferase. Science. 259:1993;219-222.
28. Oda H., Zhang S., Tsurutani N., Shimizu S., Nakatsuru Y., Aizawa S., Ishikawa T. Loss of p53 is an early event in induction of brain tumors in mice by transplacental carcinogen exposure. Cancer Res. 57:1997;646-650.
29. 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogens and therapeutic agents. Cancer Res. 50:1990;6119-6129.
30. 6-methylguanine, in transcribed genes prevents mutation of H-ras in rat mammary tumorigenesis induced by ethylnitrosourea in place of methylnitrosourea. Proc. Natl. Acad. Sci. U.S.A. 95:1998;1635-1640.
31. 6-ethylguanine in transcribed and non-transcribed genes of the rat. J. Biol. Chem. 269:1994;1681-1686.
32. 6-methylguanine-DNA methyltransferase protects against nitrosamine-induced hepatocarcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 90:1993;6468-6472.
33. Baker S.M., Bronner C.E., Zhang L., Plug A.W., Robatzek M., Warren G., Elliott M., Yu J., Ashley T., Arnheim N., Flavell R.A., Liskay R.M. Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell. 82:1995;309-319.
34. Nakane H., Takeuchi H., Yuba S., Saijo M., Nakatsu Y., Murai H., Nakatsuru Y., Ishikawa T., Hirota S., Kitamura Y., Kato Y., Tsunoda Y., Miyauchi H., Horio T., Tokunaga T., Matsunaga T., Nikaido O., Nishimune Y., Okada Y., Tanaka K. High incidence of ultraviolet-B- or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene. Nature. 377:1995;165-168.
35. Sands A.T., Abuin A., Sanchez A., Conti C.J., Bradley A. High susceptibility to ultraviolet-induced carcinogensis in mice lacking XPC. Nature. 377:1995;162-165.
36. de Wind N., Dekker M., Berns A., Radman M., te Riele H. Inactivation of the mouse Msh2 gene results in postreplicational mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to tumorigenesis. Cell. 82:1995;321-330.
37. Donehower L.A. The p53-deficient mouse: a model for basic and applied cancer studies. Semin. Cancer Biol. 7:1996;269-278.
38. Edelmann W., Cohen P., Kane M., Lan K., Morrow B., Bennet S., Umar A., Kunkel T., Cattoretti G., Chaganti R., Pollard J., Kolodner R., Kucherlapati R. Meiotic pachytene arrest in MLH1-deficient mice. Cell. 85:1996;1125-1134.
39. Prolla T.A., Abuin A., Bradley A. DNA mismatch repair deficient mice in cancer research. Sem. Cancer Biol. 7:1996;241-247.
40. de Vries A., van Steeg H. Xpa knockout mice. Semin. Cancer Biol. 7:1996;229-240.
41. Engelward B.P., Weeda G., Wyatt M.D., Broekhof J.L., De Wit J., Donker I., Allan J.M., Gold B., Hoeijmakers J.H.L., Samson L.D. Base excision repair deficient mice lacking the Aag alkyladenine DNA glycosylase. Proc. Natl. Acad. Sci. U.S.A. 94:1997;13087-13092.
42. 4-ethenocytosine or 8-oxoguanine. Proc. Natl. Acad. Sci. U.S.A. 94:1997;12869-12874.
43. van der Horst G.T.J., van Steeg H., Berg R.J.W., Morreau H., Beems R.B., van Kreij C.F., de Gruiji F.R., Bootsma D., Hoeijmakers J.H.J. Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition. Cell. 89:1997;425-435.
44. Sakumi K., Shiraishi A., Shimizu S., Tsuzuki T., Ishikawa T., Sekiguchi M. Methylnitrosourea-induced tumorigenesis in MGMT gene knockout mice. Cancer Res. 57:1997;2415-2418.
45. Wilson D.M. III, Thompson L.H. Life without DNA repair. Proc. Natl. Acad. Sci. U.S.A. 94:1997;12754-12757.
46. 6-alkylguanine-DNA alkyltransferase (AGT) and AP-endonuclease (APE). J. Biomol. Struct. Stereodyn. 16:1998;180-181.